The US healthcare market is the largest in the world, meaning that there is unequalled purchasing power, demand, and opportunity for innovation. It is one of the most important markets for Swedish life science exports. Recent developments, such as the effect of the pandemic and the coming change of power, have and will effect the US healthcare market.
Business Sweden will present their brandnew report on the Swedish-American Life Science Landscape, covering topics such as digitization, importance of prevention and access to healthcare and focus on collaboration, innovation and building back better.
In the second part of the webinar, we will listen to and interact with a panel of experts discussing the US healthcare system under the Biden administration. What changes and focus areas can we expect? How can Swedish companies navigate the uncharted waters in order to succeed in the US? These and other questions will be discussed with the panel, moderated by Swedish journalist Petra Socolovsky.
For more information on the upcoming digital delegation trip to the US and the high-level forum, please contact anna.riby[@]swecare.se.
Agenda
14:50 - 15:00 Log in and Introduction - Anna Riby, Swecare
15:00 - 15:30 Presentation of Business Sweden's Report on the Swedish-American Life Science Landscape - Megan Klumpe, consultant and Jacob Westerberg, Manager New York, Business Sweden
15:30 - 15:45 - Tomas J Philipson, Daniel Levin Chair Public Policy at University of Chicago, former Acting Chair of the White House Council of Economic Advisers
15:45 - 15:55 Q&A
15:55 - 16:00 Break
16:00 - 16:45 Introduction, Karin Hammar, SACC-DC
Panel Discussion: What to Expect in U.S. Healthcare under the Biden Administration
Moderator: Petra Socolovsky
Panellists: Kevin Holst, Finance Director, New Politics Leadership Academy; Stephanie Wiswall, Head of US Policy, US Corporate Affairs, Astra Zeneca US; Robert D Thomas, SVP Government Affairs, Elekta USA; and Michael Hoak, Associate VP, Humana
16:45 - 17:00 Q&A, Concluding Remarks
